HeartSine issues Class I recall of defibrillators

HeartSine has notified customers that certain Samaritan 300/300P public access defibrillator (PAD) devices have been found to intermittently turn on and off, which may eventually deplete the battery. Thus, the company is issuing a Class I recall of the devices.

Samaritan 300/300P PAD devices are intended for use on patients experiencing sudden cardiac arrest.

In addition and separately, certain Samaritan 300/300P PAD devices containing early versions of the battery management software may misinterpret a temporary drop in battery voltage as signaling a low battery, resulting in the device turning itself off, according to the recall notice, posted on the FDA site Nov. 19. A device experiencing either condition could be unable to deliver therapy during a cardiac event.

The Samaritan 300/300P PAD devices with the following serial numbers are affected by this recall:

  • 0400000501 to 0700032917
  • 08A00035000 to 10A0070753
  • 10C00200000 to 10C00210106

The company said the affected devices were manufactured and distributed from Aug. 1, 2004, through Jan. 31, 2011.

The company issued a letter to customers on Sept. 11, describing the problem and provided instructions for correction. Newtown, Pa.-based HeartSine has requested that customers follow the instructions detailed in their letter dated Sept. 11, to ensure that affected devices are able to provide therapy if a sudden cardiac arrest event occurs.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.